Related Experiment Videos

Demographic influences on antibiotic prescribing for pediatric acute otitis media

Douglas Sidell1, Nina L Shapiro, Neil Bhattacharyya

  • 1Division of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1624, USA. dsidell@mednet.ucla.edu

Insights

Most children with acute otitis media (AOM) receive antibiotic prescriptions. Race, ethnicity, and insurance status did not significantly impact AOM antibiotic prescribing patterns in this study.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Health Services Research

Background:

  • Acute otitis media (AOM) is a common childhood illness requiring medical management.
  • Antibiotic prescribing patterns for AOM are influenced by various factors, including patient demographics.
  • Understanding these patterns is crucial for optimizing treatment and combating antibiotic resistance.

Purpose of the Study:

  • To investigate the epidemiologic antibiotic treatment patterns for acute otitis media (AOM) in children.
  • To assess the potential impact of race, ethnicity, and insurance status on AOM medical management.
  • To analyze antibiotic prescribing trends in a national ambulatory care setting.

Main Methods:

  • Cross-sectional analysis of the National Ambulatory Medical Care Survey (2006-2008).
  • Included isolated AOM cases in children aged 16 years or younger.
  • Multivariate logistic regression analyzed the influence of age, sex, race, ethnicity, and insurance type on antibiotic prescribing.

Main Results:

  • Approximately 15.8 million AOM cases were studied.
  • 83.1% of children received an antibiotic prescription; amoxicillin was most common.
  • Insurance status, ethnicity, race, age, and sex did not significantly influence antibiotic prescription likelihood (P > .10).

Conclusions:

  • The majority of children treated for AOM receive antibiotic prescriptions.
  • Demographic factors including race, ethnicity, and insurance type do not significantly affect AOM antibiotic prescribing rates.
  • Nearly all pediatric patients in this cohort had medical insurance.
Abstract

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...